General Information of Drug (ID: DM0SZQY)

Drug Name
QBS10072S
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
PubChem CID
118276683
TTD ID
DCXB47

References

1 ClinicalTrials.gov (NCT04430842) Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S. U.S. National Institutes of Health.